Simon Amy 4
4 · Beam Therapeutics Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Simon Amy
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-07-01$23.76/sh−502$11,928→ 69,553 total - Sale
Common Stock
2024-07-02$22.95/sh−748$17,167→ 68,805 total
Footnotes (3)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on June 30, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
- [F2]This reflects a correction to the previously reported amount of securities beneficially owned. Prior to the reported transaction, the Reporting Person beneficially owned 70,055 shares of common stock, not 70,060 shares.
- [F3]These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.